This side activity is partially responsible for adverse drug reaction in child acute lymphoblastic leukemia (ALL) therapy but may not be significant for food applications. 2.1.
← all excerpts
Recent advances in L-Asparaginase enzyme production and formulation development for acrylamide reduction during food processing.
1
—
—